Skip to main content
Top
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2022

Open Access 01-12-2022 | Public Health | Research

Navigating intersecting public health crises: a qualitative study of people with opioid use disorders' experiences during the COVID-19 pandemic

Authors: Dennis P. Watson, Monte D. Staton, Christine E. Grella, Christy K. Scott, Michael L. Dennis

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2022

Login to get access

Abstract

Background

The decades-long opioid epidemic and the more recent COVID-19 pandemic are two interacting events with significant public health impacts for people with opioid use disorder (OUD). Most published studies regarding the intersection of these two public health crises have focused on community, state, or national trends using pre-existing data. There is a need for complementary qualitative research aimed at identifying how people with opioid use disorder (OUD) are understanding, experiencing, and navigating this unprecedented time. The current study examines understandings and experiences of people with OUD while they have navigated these crises.

Methods

The study was guided by a pragmatic lens. We conducted brief semi-structured qualitative interviews with 25 individuals in Chicago, the majority of which had received methadone treatment during the pandemic. Thematic inductive analysis was guided by primary interview questions.

Results

The sample represents a high-risk group, being composed mostly of older non-Hispanic African American males and having considerable socioeconomic barriers. Themes demonstrate how individuals are keeping safe despite limited knowledge of COVID-19, how the pandemic has increased treatment motivation for some, how adaptations impacted treatment and recovery supports, how the availability social support had been reduced, and difficulties individuals had keeping or obtaining financial support.

Conclusions

The findings can be useful for informing future public health response to ensure appropriate treatment access and supports are available. In particular are the need for treatment providers to ensure people with OUD receive appropriate and understandable health crisis-related information and ensuring funds are appropriately allocated to address mental health impacts of social isolation. Finally, there is a need for appropriate financial and infrastructure supports to ensure health and treatment access disparities are not exacerbated for those in greatest need.
Footnotes
1
These data came from the research projects from which participants were sampled, which was missing for one participant.
 
Literature
1.
go back to reference Glober N, Mohler G, Huynh P, Arkins T, O’Donnell D, Carter J, et al. Impact of COVID-19 pandemic on drug overdoses in Indianapolis. J Urban Health. 2020;97:802–7.PubMedPubMedCentralCrossRef Glober N, Mohler G, Huynh P, Arkins T, O’Donnell D, Carter J, et al. Impact of COVID-19 pandemic on drug overdoses in Indianapolis. J Urban Health. 2020;97:802–7.PubMedPubMedCentralCrossRef
2.
go back to reference Rodda LN, West KL, LeSaint KT. Opioid overdose–related emergency department visits and accidental deaths during the COVID-19 pandemic. J Urban Health. 2020;97:808–13.PubMedPubMedCentralCrossRef Rodda LN, West KL, LeSaint KT. Opioid overdose–related emergency department visits and accidental deaths during the COVID-19 pandemic. J Urban Health. 2020;97:808–13.PubMedPubMedCentralCrossRef
3.
go back to reference Slavova S, Rock P, Bush HM, Quesinberry D, Walsh SL. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend. 2020;214:108176.PubMedPubMedCentralCrossRef Slavova S, Rock P, Bush HM, Quesinberry D, Walsh SL. Signal of increased opioid overdose during COVID-19 from emergency medical services data. Drug Alcohol Depend. 2020;214:108176.PubMedPubMedCentralCrossRef
5.
go back to reference Browne T, Gold MS, Martin DM. The rapidly changing composition of the global street drug supply and its effects on high-risk groups for COVID-19. Current Psychopharmacology. 2021;10:138–54.CrossRef Browne T, Gold MS, Martin DM. The rapidly changing composition of the global street drug supply and its effects on high-risk groups for COVID-19. Current Psychopharmacology. 2021;10:138–54.CrossRef
6.
go back to reference Rosenbaum J, Lucas N, Zandrow G, Satz WA, Isenberg D, D’Orazio J, et al. Impact of a shelter-in-place order during the COVID-19 pandemic on the incidence of opioid overdoses. Am J Emerg Med. 2021;41:51–4.PubMedCrossRef Rosenbaum J, Lucas N, Zandrow G, Satz WA, Isenberg D, D’Orazio J, et al. Impact of a shelter-in-place order during the COVID-19 pandemic on the incidence of opioid overdoses. Am J Emerg Med. 2021;41:51–4.PubMedCrossRef
7.
go back to reference DiGennaro C, Garcia GGP, Stringfellow EJ, Wakeman S, Jalali MS. Changes in characteristics of drug overdose death trends during the COVID-19 pandemic. Int J Drug Policy. 2021;98:103392. DiGennaro C, Garcia GGP, Stringfellow EJ, Wakeman S, Jalali MS. Changes in characteristics of drug overdose death trends during the COVID-19 pandemic. Int J Drug Policy. 2021;98:103392.
8.
go back to reference Linas BP, Savinkina A, Barbosa C, Mueller PP, Cerdá M, Keyes K, et al. A clash of epidemics: impact of the COVID-19 pandemic response on opioid overdose. J Subst Abuse Treat. 2021;120:108158.PubMedCrossRef Linas BP, Savinkina A, Barbosa C, Mueller PP, Cerdá M, Keyes K, et al. A clash of epidemics: impact of the COVID-19 pandemic response on opioid overdose. J Subst Abuse Treat. 2021;120:108158.PubMedCrossRef
9.
go back to reference Galarneau LR, Hilburt J, O’Neill ZR, Buxton JA, Scheuermeyer FX, Dong K, et al. Experiences of people with opioid use disorder during the COVID-19 pandemic: a qualitative study. PloS One. 2021;16:e0255396.PubMedPubMedCentralCrossRef Galarneau LR, Hilburt J, O’Neill ZR, Buxton JA, Scheuermeyer FX, Dong K, et al. Experiences of people with opioid use disorder during the COVID-19 pandemic: a qualitative study. PloS One. 2021;16:e0255396.PubMedPubMedCentralCrossRef
10.
go back to reference Russell C, Ali F, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): a national qualitative study. J Subst Abuse Treat. 2021;129:108374.PubMedCrossRef Russell C, Ali F, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): a national qualitative study. J Subst Abuse Treat. 2021;129:108374.PubMedCrossRef
11.
go back to reference Alexander GC, Stoller KB, Haffajee RL, Saloner B. An Epidemic in the midst of a pandemic: opioid use disorder and COVID-19. Ann Intern Med. 2020;173:57-8. Alexander GC, Stoller KB, Haffajee RL, Saloner B. An Epidemic in the midst of a pandemic: opioid use disorder and COVID-19. Ann Intern Med. 2020;173:57-8.
12.
go back to reference Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med. 2020;M20–1212 Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med. 2020;M20–1212
13.
go back to reference Wei Y, Shah R. Substance use disorder in the COVID-19 pandemic: a systematic review of vulnerabilities and complications. Pharmaceuticals. 2020;13:155.PubMedCentralCrossRef Wei Y, Shah R. Substance use disorder in the COVID-19 pandemic: a systematic review of vulnerabilities and complications. Pharmaceuticals. 2020;13:155.PubMedCentralCrossRef
14.
go back to reference Qeadan F, Tingey B, Bern R, Porucznik CA, English K, Saeed AI, et al. Opioid use disorder and health service utilization among COVID-19 patients in the US: a nationwide cohort from the Cerner Real-World Data. EClinicalMedicine. 2021;37:100938.PubMedPubMedCentralCrossRef Qeadan F, Tingey B, Bern R, Porucznik CA, English K, Saeed AI, et al. Opioid use disorder and health service utilization among COVID-19 patients in the US: a nationwide cohort from the Cerner Real-World Data. EClinicalMedicine. 2021;37:100938.PubMedPubMedCentralCrossRef
15.
go back to reference Nguyen T, Buxton JA. Pathways between COVID-19 public health responses and increasing overdose risks: a rapid review and conceptual framework. Int J Drug Policy. 2021;93:103236.PubMedPubMedCentralCrossRef Nguyen T, Buxton JA. Pathways between COVID-19 public health responses and increasing overdose risks: a rapid review and conceptual framework. Int J Drug Policy. 2021;93:103236.PubMedPubMedCentralCrossRef
16.
go back to reference Niles JK, Gudin J, Radcliff J, Kaufman HW. The opioid epidemic within the COVID-19 pandemic: drug testing in 2020. Popul Health Manag. 2021;24:S43–51.PubMedCrossRef Niles JK, Gudin J, Radcliff J, Kaufman HW. The opioid epidemic within the COVID-19 pandemic: drug testing in 2020. Popul Health Manag. 2021;24:S43–51.PubMedCrossRef
17.
18.
go back to reference Friedman J, Beletsky L, Jordan A. Surging racial disparities in the U.S. overdose crisis. AJP. 2022;179:166–9.CrossRef Friedman J, Beletsky L, Jordan A. Surging racial disparities in the U.S. overdose crisis. AJP. 2022;179:166–9.CrossRef
19.
20.
21.
go back to reference Knudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Eval Program Plann. 2011;34:375–81.PubMedPubMedCentralCrossRef Knudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Eval Program Plann. 2011;34:375–81.PubMedPubMedCentralCrossRef
22.
go back to reference Langabeer J, Champagne-Langabeer T, Luber SD, Prater SJ, Stotts A, Kirages K, et al. Outreach to people who survive opioid overdose: linkage and retention in treatment. J Subst Abuse Treat. 2020;111:11–5.PubMedCrossRef Langabeer J, Champagne-Langabeer T, Luber SD, Prater SJ, Stotts A, Kirages K, et al. Outreach to people who survive opioid overdose: linkage and retention in treatment. J Subst Abuse Treat. 2020;111:11–5.PubMedCrossRef
23.
go back to reference Griffin AR, Der-Martirosian C, Gable A, Wyte-Lake T, Dobalian A. A crisis within a crisis: the extended closure of an opioid treatment program after hurricane sandy. Journal of Drug Issues. 2018;48:536–45.CrossRef Griffin AR, Der-Martirosian C, Gable A, Wyte-Lake T, Dobalian A. A crisis within a crisis: the extended closure of an opioid treatment program after hurricane sandy. Journal of Drug Issues. 2018;48:536–45.CrossRef
24.
go back to reference United States Substance Abuse and Mental Health Services Administration. Medications for opioid use disorder-for healthcare and addiction professionals, policymakers, patients, and families: Treatment Improvement Protocol TIP 63. Washington DC: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 2018. United States Substance Abuse and Mental Health Services Administration. Medications for opioid use disorder-for healthcare and addiction professionals, policymakers, patients, and families: Treatment Improvement Protocol TIP 63. Washington DC: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment; 2018.
25.
go back to reference Green TC, Bratberg J, Finnell DS. Opioid use disorder and the COVID 19 pandemic: a call to sustain regulatory easements and further expand access to treatment. Substance Abuse. 2020;41:147–9.PubMedCrossRef Green TC, Bratberg J, Finnell DS. Opioid use disorder and the COVID 19 pandemic: a call to sustain regulatory easements and further expand access to treatment. Substance Abuse. 2020;41:147–9.PubMedCrossRef
26.
go back to reference Figgatt MC, Salazar Z, Day E, Vincent L, Dasgupta N. Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. J Subst Abuse Treat. 2021;123:108276.PubMedPubMedCentralCrossRef Figgatt MC, Salazar Z, Day E, Vincent L, Dasgupta N. Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19. J Subst Abuse Treat. 2021;123:108276.PubMedPubMedCentralCrossRef
27.
go back to reference Henry BF, Campbell A, Hunt T, Johnson JK, Mandavia AD, Chaple M, et al. COVID-19 related substance use services policy changes: policymaker perspectives on policy development & implementation. J Subst Abuse Treat. 2021;133:108550.PubMedCrossRef Henry BF, Campbell A, Hunt T, Johnson JK, Mandavia AD, Chaple M, et al. COVID-19 related substance use services policy changes: policymaker perspectives on policy development & implementation. J Subst Abuse Treat. 2021;133:108550.PubMedCrossRef
28.
go back to reference Charmaz K. The power of constructivist grounded theory for critical inquiry. Qual Inq. 2017;23:34–45.CrossRef Charmaz K. The power of constructivist grounded theory for critical inquiry. Qual Inq. 2017;23:34–45.CrossRef
29.
go back to reference Goldkuhl G. Pragmatism vs interpretivism in qualitative information systems research. Eur J Inf Syst. 2012;21:135–46.CrossRef Goldkuhl G. Pragmatism vs interpretivism in qualitative information systems research. Eur J Inf Syst. 2012;21:135–46.CrossRef
30.
go back to reference Morgan DL. Pragmatism as a paradigm for social research. Qual Inq. 2014;20:1045–53.CrossRef Morgan DL. Pragmatism as a paradigm for social research. Qual Inq. 2014;20:1045–53.CrossRef
31.
go back to reference Vindrola-Padros C, Chisnall G, Cooper S, Dowrick A, Djellouli N, Symmons SM, et al. Carrying out rapid qualitative research during a pandemic: emerging lessons From COVID-19. Qual Health Res. 2020;30:2192–204.PubMedPubMedCentralCrossRef Vindrola-Padros C, Chisnall G, Cooper S, Dowrick A, Djellouli N, Symmons SM, et al. Carrying out rapid qualitative research during a pandemic: emerging lessons From COVID-19. Qual Health Res. 2020;30:2192–204.PubMedPubMedCentralCrossRef
32.
go back to reference Avis M. Do we need methodological theory to do qualitative research? Qual Health Res. 2003;13:995–1004.PubMedCrossRef Avis M. Do we need methodological theory to do qualitative research? Qual Health Res. 2003;13:995–1004.PubMedCrossRef
33.
go back to reference Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52:1893–907.PubMedCrossRef Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52:1893–907.PubMedCrossRef
34.
go back to reference Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27:237–46.CrossRef Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27:237–46.CrossRef
35.
go back to reference Singh GK, Kim IE, Girmay M, Perry C, Daus GP, Vedamuthu IP, et al. Opioid epidemic in the United States: empirical trends, and a literature review of social determinants and epidemiological, pain management, and treatment patterns. Int J MCH AIDS. 2019;8:89–100.PubMedPubMedCentralCrossRef Singh GK, Kim IE, Girmay M, Perry C, Daus GP, Vedamuthu IP, et al. Opioid epidemic in the United States: empirical trends, and a literature review of social determinants and epidemiological, pain management, and treatment patterns. Int J MCH AIDS. 2019;8:89–100.PubMedPubMedCentralCrossRef
36.
go back to reference Barocas JA, Wang J, Marshall BDL, LaRochelle MR, Bettano A, Bernson D, et al. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug Alcohol Depend. 2019;200:59–63.PubMedPubMedCentralCrossRef Barocas JA, Wang J, Marshall BDL, LaRochelle MR, Bettano A, Bernson D, et al. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug Alcohol Depend. 2019;200:59–63.PubMedPubMedCentralCrossRef
37.
go back to reference Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep. 2002;117(Suppl 1):S135–45.PubMedPubMedCentral Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep. 2002;117(Suppl 1):S135–45.PubMedPubMedCentral
38.
go back to reference El-Bassel N, Shoptaw S, Goodman-Meza D, Ono H. Addressing long overdue social and structural determinants of the opioid epidemic. Drug and Alcohol Depend. 2021;222:108679.CrossRef El-Bassel N, Shoptaw S, Goodman-Meza D, Ono H. Addressing long overdue social and structural determinants of the opioid epidemic. Drug and Alcohol Depend. 2021;222:108679.CrossRef
39.
go back to reference Jenkins WD, Bolinski R, Bresett J, Van Ham B, Fletcher S, Walters S, et al. COVID‐19 During the opioid epidemic – exacerbation of stigma and vulnerabilities. J Rural Health. 2020;jrh.12442. Jenkins WD, Bolinski R, Bresett J, Van Ham B, Fletcher S, Walters S, et al. COVID‐19 During the opioid epidemic – exacerbation of stigma and vulnerabilities. J Rural Health. 2020;jrh.12442.
40.
go back to reference Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet. 2020;395:912–20.CrossRef Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet. 2020;395:912–20.CrossRef
41.
go back to reference MacLean RR, Armstrong JL, Sofuoglu M. Stress and opioid use disorder: a systematic review. Addict Behav. 2019;98:106010.PubMedCrossRef MacLean RR, Armstrong JL, Sofuoglu M. Stress and opioid use disorder: a systematic review. Addict Behav. 2019;98:106010.PubMedCrossRef
42.
go back to reference Streck JM, Kalkhoran S, Bearnot B, Gupta PS, Kalagher KM, Regan S, et al. Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic. Drug and Alcohol Depend. 2021;218:108438.CrossRef Streck JM, Kalkhoran S, Bearnot B, Gupta PS, Kalagher KM, Regan S, et al. Perceived risk, attitudes, and behavior of cigarette smokers and nicotine vapers receiving buprenorphine treatment for opioid use disorder during the COVID-19 pandemic. Drug and Alcohol Depend. 2021;218:108438.CrossRef
43.
go back to reference Ali F, Russell C, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada. Int J Drug Policy. 2021;93:103237.PubMedCrossRef Ali F, Russell C, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada. Int J Drug Policy. 2021;93:103237.PubMedCrossRef
44.
go back to reference Hunter SB, Dopp AR, Ober AJ, Uscher-Pines L. Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: a qualitative study. J Subst Abuse Treat. 2021;124:108288.PubMedPubMedCentralCrossRef Hunter SB, Dopp AR, Ober AJ, Uscher-Pines L. Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: a qualitative study. J Subst Abuse Treat. 2021;124:108288.PubMedPubMedCentralCrossRef
45.
go back to reference Deering DEA, Sheridan J, Sellman JD, Adamson SJ, Pooley S, Robertson R, et al. Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness. Addict Behav. 2011;36:636–42.PubMedCrossRef Deering DEA, Sheridan J, Sellman JD, Adamson SJ, Pooley S, Robertson R, et al. Consumer and treatment provider perspectives on reducing barriers to opioid substitution treatment and improving treatment attractiveness. Addict Behav. 2011;36:636–42.PubMedCrossRef
46.
go back to reference Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, et al. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:483–9.PubMedCrossRef Gerra G, Saenz E, Busse A, Maremmani I, Ciccocioppo R, Zaimovic A, et al. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:483–9.PubMedCrossRef
47.
go back to reference Khatri UG, Perrone J. Opioid use disorder and COVID-19: crashing of the crises. J Addict Med. 2020;14:e6-7.PubMedCrossRef Khatri UG, Perrone J. Opioid use disorder and COVID-19: crashing of the crises. J Addict Med. 2020;14:e6-7.PubMedCrossRef
48.
go back to reference Becker SJ, Garner BR, Hartzler BJ. Is necessity also the mother of implementation? COVID-19 and the implementation of evidence-based treatments for opioid use disorders. J Subst Abuse Treat. 2021;122:108210.PubMedCrossRef Becker SJ, Garner BR, Hartzler BJ. Is necessity also the mother of implementation? COVID-19 and the implementation of evidence-based treatments for opioid use disorders. J Subst Abuse Treat. 2021;122:108210.PubMedCrossRef
49.
go back to reference Hughto JMW, Peterson L, Perry NS, Donoyan A, Mimiaga MJ, Nelson KM, et al. The provision of counseling to patients receiving medications for opioid use disorder: telehealth innovations and challenges in the age of COVID-19. J Subst Abuse Treat. 2021;120:108163.PubMedCrossRef Hughto JMW, Peterson L, Perry NS, Donoyan A, Mimiaga MJ, Nelson KM, et al. The provision of counseling to patients receiving medications for opioid use disorder: telehealth innovations and challenges in the age of COVID-19. J Subst Abuse Treat. 2021;120:108163.PubMedCrossRef
50.
go back to reference Cloud W, Granfield R. Conceptualizing recovery capital: expansion of a theoretical construct. Subst Use Misuse. 2008;43:1971–86.PubMedCrossRef Cloud W, Granfield R. Conceptualizing recovery capital: expansion of a theoretical construct. Subst Use Misuse. 2008;43:1971–86.PubMedCrossRef
51.
go back to reference Silva MJ, Kelly Z. The escalation of the opioid epidemic due to COVID-19 and resulting lessons about treatment alternatives. Am J Manag Care. 2020;26:3. Silva MJ, Kelly Z. The escalation of the opioid epidemic due to COVID-19 and resulting lessons about treatment alternatives. Am J Manag Care. 2020;26:3.
52.
go back to reference Dietze P, Jolley D, Fry CL, Bammer G, Moore D. When is a little knowledge dangerous?: circumstances of recent heroin overdose and links to knowledge of overdose risk factors. Drug Alcohol Depend. 2006;84:223–30.PubMedCrossRef Dietze P, Jolley D, Fry CL, Bammer G, Moore D. When is a little knowledge dangerous?: circumstances of recent heroin overdose and links to knowledge of overdose risk factors. Drug Alcohol Depend. 2006;84:223–30.PubMedCrossRef
54.
go back to reference Kumar N, Oles W, Howell BA, Janmohamed K, Lee ST, Funaro MC, et al. The role of social network support in treatment outcomes for medication for opioid use disorder: a systematic review. J Subst Abuse Treat. 2021;127:108367.PubMedCrossRef Kumar N, Oles W, Howell BA, Janmohamed K, Lee ST, Funaro MC, et al. The role of social network support in treatment outcomes for medication for opioid use disorder: a systematic review. J Subst Abuse Treat. 2021;127:108367.PubMedCrossRef
55.
go back to reference Galea S, Merchant RM, Lurie N. The mental health consequences of COVID-19 and physical distancing: the need for prevention and early intervention. JAMA Intern Med. 2020;180:817.PubMedCrossRef Galea S, Merchant RM, Lurie N. The mental health consequences of COVID-19 and physical distancing: the need for prevention and early intervention. JAMA Intern Med. 2020;180:817.PubMedCrossRef
56.
go back to reference Kleinman MB, Felton JW, Johnson A, Magidson JF. “I have to be around people that are doing what I’m doing”: the importance of expanding the peer recovery coach role in treatment of opioid use disorder in the face of COVID-19 health disparities. J Subst Abuse Treat. 2021;122:108182.PubMedCrossRef Kleinman MB, Felton JW, Johnson A, Magidson JF. “I have to be around people that are doing what I’m doing”: the importance of expanding the peer recovery coach role in treatment of opioid use disorder in the face of COVID-19 health disparities. J Subst Abuse Treat. 2021;122:108182.PubMedCrossRef
58.
go back to reference Dunphy C, Peterson C, Zhang K, Jones CM. Do out-of-pocket costs influence retention and adherence to medications for opioid use disorder? Drug and Alcohol Depend. 2021;225:108784.CrossRef Dunphy C, Peterson C, Zhang K, Jones CM. Do out-of-pocket costs influence retention and adherence to medications for opioid use disorder? Drug and Alcohol Depend. 2021;225:108784.CrossRef
59.
go back to reference Carminati L. Generalizability in qualitative research: a tale of two traditions. Qual Health Res. 2018;28:2094–101.PubMedCrossRef Carminati L. Generalizability in qualitative research: a tale of two traditions. Qual Health Res. 2018;28:2094–101.PubMedCrossRef
60.
go back to reference Lincoln YS, Guba EG. Naturalistic Inquiry. Newbury Park: SAGE; 1985. Lincoln YS, Guba EG. Naturalistic Inquiry. Newbury Park: SAGE; 1985.
61.
go back to reference Aikens B, Jasmin W, Chung I, Arunkumar P, Kiely M, Aks S, et al. Annual opioid surveillance report-Chicago 2019. 2021. Aikens B, Jasmin W, Chung I, Arunkumar P, Kiely M, Aks S, et al. Annual opioid surveillance report-Chicago 2019. 2021.
62.
go back to reference Nunes EV, Levin FR, Reilly MP, El-Bassel N. Medication treatment for opioid use disorder in the age of COVID-19: can new regulations modify the opioid cascade? J Subst Abuse Treat. 2021;122:108196.PubMedCrossRef Nunes EV, Levin FR, Reilly MP, El-Bassel N. Medication treatment for opioid use disorder in the age of COVID-19: can new regulations modify the opioid cascade? J Subst Abuse Treat. 2021;122:108196.PubMedCrossRef
Metadata
Title
Navigating intersecting public health crises: a qualitative study of people with opioid use disorders' experiences during the COVID-19 pandemic
Authors
Dennis P. Watson
Monte D. Staton
Christine E. Grella
Christy K. Scott
Michael L. Dennis
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2022
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/s13011-022-00449-3

Other articles of this Issue 1/2022

Substance Abuse Treatment, Prevention, and Policy 1/2022 Go to the issue